Phathom Pharmaceuticals Inc (PHAT) Inventory Turnover Ratio, from third quarter 2026 to third quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 
Phathom Pharmaceuticals Inc   (NASDAQ: PHAT)
 

Phathom Pharmaceuticals Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Phathom Pharmaceuticals Inc inventory turnover ratio, the Phathom Pharmaceuticals Inc 's ability to sell and replace its inventory in the third quarter 2026, sequentially increased to 7.76 in the third quarter 2026, a new company high. Average inventory processing period, for the Phathom Pharmaceuticals Inc in Sep 30 2026 quarter, has decreased to 47 days, compare to 52 days, in the Jun 30 2026 quarter.

Within Healthcare sector 46 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 517 in the second quarter 2026, to 607.

PHAT Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Phathom Pharmaceuticals Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

PHAT Inventory Turnover Ratio (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Inventory Growth 111.35 % 124.8 % 105.56 % 72.01 % 16.07 %
Y / Y Cost of Sales Growth 196.72 % 199.64 % 222.13 % 100.45 % 162.73 %
Inventory Turnover Ratio (TTM) 7.76 7.01 6.48 5.75 5.6
PHAT's Total Ranking # 607 # 517 # 391 # 410 #
Average inventory processing period 47 52 56 63 65
Seq. Inventory Growth -1.05 % 18.52 % 17.94 % 52.81 % 5.25 %
Seq. Cost of Sales Growth 21.67 % 25.84 % 56.87 % 23.54 % 22.87 %




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 9
Healthcare Sector # 47
Overall Market # 607

Inventory Turnover Ratio Statistics
High Average Low
7.76 4.44 0.82
(Sep 30 2026)   (Mar 31 2024)



PHAT Company Profile >> Back to PHAT Efficiency Comparisons >> Compare PHAT Inventory Turnover Ratio to its Competitors

Financial Statements
Phathom Pharmaceuticals Inc 's Inventories $ 8 Millions Visit PHAT's Balance sheet
Phathom Pharmaceuticals Inc 's Cost of Revenues TTM $ 53 Millions Visit PHAT's Income Statement
What are PHAT's Sales? Visit PHAT's Sales by Segment

Other Inventory Turnover Ratios
Phathom Pharmaceuticals Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
PHAT's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for PHAT's Competitors
Inventory Turnover Ratio for PHAT's Suppliers
Inventory Turnover Ratio for PHAT's Customers

You may also want to know
PHAT's Sales Growth Rates PHAT's Pe Price to earnings ratio PHAT's Receivables Turnover Ratio PHAT's Stock Quote
PHAT's Net Income Growth Rates PHAT's Ps Price to Sales ratio PHAT's Sales per Employee PHAT's Asset Turnover Ratio
PHAT's Net Margin PHAT's Pb Price to Book ratio PHAT's Financial Strength Ratios PHAT's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Sep 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Sep 30 2026 Inventories at quarter ending Sep 30 2026
Precipio inc   17.63 $ 15.391  Millions$ 1  Millions
Cryo cell International Inc   16.60 $ 6.680  Millions$ 0  Millions
Alnylam Pharmaceuticals Inc   12.28 $ 1,135.254  Millions$ 92  Millions
Brightspring Health Services Inc   11.57 $ 7,583.638  Millions$ 655  Millions
Tarsus Pharmaceuticals Inc   10.68 $ 49.325  Millions$ 5  Millions
Sotera Health Company  10.25 $ 558.509  Millions$ 54  Millions
Lantheus Holdings Inc   9.76 $ 604.826  Millions$ 62  Millions
Vanda Pharmaceuticals Inc   8.70 $ 14.704  Millions$ 2  Millions
Phathom Pharmaceuticals Inc   7.76 $ 53.106  Millions$ 7  Millions
Novavax inc   7.03 $ 90.533  Millions$ 13  Millions
Carlisle Companies Incorporated  6.99 $ 3,406.400  Millions$ 488  Millions
Cardiff Lexington Corporation  6.98 $ 3.768  Millions$ 1  Millions
Carlsmed Inc   6.91 $ 15.844  Millions$ 2  Millions
Caredx Inc   6.42 $ 111.106  Millions$ 17  Millions
Edap Tms Sa  6.14 $ 60.833  Millions$ 10  Millions
Transmedics Group Inc   5.70 $ 301.220  Millions$ 53  Millions
Bristol myers Squibb Company  5.65 $ 15,389.000  Millions$ 2,722  Millions
Avantor Inc   5.48 $ 4,539.200  Millions$ 828  Millions
Tactile Systems Technology Inc   5.25 $ 82.718  Millions$ 16  Millions
Integer Holdings Corporation  4.98 $ 1,376.268  Millions$ 276  Millions
Ge Healthcare Technologies Inc   4.69 $ 11,372.000  Millions$ 2,425  Millions
West Pharmaceutical Services Inc   4.69 $ 2,120.200  Millions$ 452  Millions
Henry Schein Inc   4.63 $ 9,395.000  Millions$ 2,031  Millions
Cryoport inc   4.60 $ 102.157  Millions$ 22  Millions
Myomo Inc   4.58 $ 14.802  Millions$ 3  Millions
Idexx Laboratories Inc  4.52 $ 1,743.379  Millions$ 386  Millions
Autolus Therapeutics Plc  4.34 $ 88.293  Millions$ 20  Millions
Medinotec Inc   4.28 $ 5.143  Millions$ 1  Millions
Electromed Inc   4.18 $ 14.878  Millions$ 4  Millions
Intelligent Bio Solutions Inc   4.14 $ 2.206  Millions$ 1  Millions

Date modified: 2026-10-30T13:20:40+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.